Lobby organisation
Breakthrough T1D
NGO or non-profit · Health & pharma · HQ: United States · Transparency Register entry
As of 7 November 2026, Breakthrough T1D appears in 12 declared MEP meetings (11 different MEPs), most often with European People's Party.
In their own words
“Breakthrough T1D is the leading global organization funding type 1 diabetes research, with the goal to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, Breakthrough T1D aims to: 1. Fund innovative research in type 1 diabetes worldwide.”
Read the rest of the statementShow less of the statement
“Our focus is to improve the lives of people living with diabetes today as well as tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications 2. Advocate for continued public funding for diabetes research as well as raise awareness of the financial, medical and emotional costs of diabetes […]”
Stated goals from the organisation's own Transparency Register filing - the text on file breaks off mid-sentence where marked […].
Who they meet, and when
Which groups they meet
Share of this organisation's 12 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2026. Bar length is relative to its busiest year (8 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 12 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 10 Jun 2026 | Aurelijus Veryga | Exchange of Views on the EU Biotech Act |
| 10 Jun 2026 | Elena Nevado del Campo | Presentación roadmap diabetes tipo 1 |
| 23 Apr 2026 | Tiemo Wölken | Biotech Act |
| 23 Apr 2026 | Ingeborg ter Laak | Biotech Act |
| 22 Apr 2026 | Wouter Beke | EU Biotech Act I |
| 21 Apr 2026 | Stine Bosse | Biotech Act |
| 21 Apr 2026 | Vytenis Povilas Andriukaitis | Biotech Act |
| 4 Feb 2026 | Nicolás González Casares | Biotech Act |
| 12 Nov 2025 | Elena Nevado del Campo | Diabetes T1 |
| 4 Jun 2025 | András Tivadar Kulja | Unmet needs ofthe T1D community |
| 2 Jun 2025 | Eero Heinäluoma | Diabetes research |
| 14 Jan 2025 | Tomislav Sokol | Health policy |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.